Company intelligence / Profile preview

Beyond Next Ventures

Chuo-ku, Tokyo, Japanbeyondnextventures.com ↗

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Beyond Next Ventures has invested in approximately 80 deep-tech startups since 2014—primarily in Japan and India—including multiple healthcare/life science ventures. The firm has supported exits through IPOs (e.g., SUSMED) and M&A (e.g., Repertoire Genesis)[3][4]. It operates shared wet labs for early-stage bio ventures and provides business-building support beyond capital investment[3][5].

Therapeutic areas: OncologyCardiovascularNeurologyInfectious Diseases
Modalities: Small moleculeMonoclonal antibodyCell therapyDigital therapeuticsMedical devices
Industry: Investors

Partnerships

T-Hub India partnership on deep tech/social innovation ecosystemPanasonic Ignition Challenge II venture partner role

Beyond the preview

Go deeper on Beyond Next Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beyond Next Ventures.

Explore the full profile